Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 13,102,250 | 10,699,440 | 9,803,839 | 8,065,916 | 7,333,800 |
| Cost of Goods | 2,913,890 | 2,358,895 | 2,200,522 | 1,841,058 | 1,890,339 |
| Gross Profit | 10,188,360 | 8,340,547 | 7,147,354 | 6,224,858 | 5,443,461 |
| Operating Expenses | 8,251,630 | 7,179,297 | 6,189,559 | 5,525,793 | 4,678,558 |
| Operating Income | 1,937,621 | 1,162,144 | 1,414,280 | 699,123 | 765,242 |
| Interest Expense | 548,827 | 527,462 | 409,603 | 303,074 | 255,594 |
| Other Income | 477,025 | 1,042,337 | 455,076 | 772,355 | 539,149 |
| Pre-tax Income | 1,865,819 | 1,677,019 | 1,459,753 | 1,168,404 | 1,048,797 |
| Income Tax | 439,878 | 401,202 | 531,330 | 389,944 | 303,005 |
| Net Income Continuous | 219,747 | 212,582 | 148,300 | 128,500 | 126,200 |
| Net Income | $1,425,941 | $1,275,817 | $928,423 | $778,460 | $745,792 |
| EPS Basic Total Ops | 0.03 | 0.19 | 0.14 | 0.12 | 0.14 |
| EPS Basic Continuous Ops | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
| EPS Diluted Total Ops | 0.03 | 0.17 | N/A | 0.12 | 0.12 |
| EPS Diluted Continuous Ops | 0.03 | 0.03 | N/A | 0.02 | 0.02 |
| EBITDA(a) | $2,734,128 | $1,857,479 | $2,005,414 | $1,219,810 | $1,236,692 |